Core Points - The "2025 Skill Construction Work Plan" for Henan Province aims to train over 2 million individuals in vocational skills, with 650,000 receiving government subsidies [1] - The plan includes ten special training programs focusing on high-quality skilled talent to meet the needs of industrial transformation and upgrading [1] Group 1: Advanced Manufacturing Sector - The plan targets key industrial chains and clusters in advanced manufacturing, including automotive, pharmaceutical, and electrical machinery sectors, with a goal of training 200,000 individuals and adding 60,000 high-skilled talents annually [1] Group 2: Modern Service Sector - The training initiatives will focus on health services for the elderly and children, aiming to train 350,000 individuals and add 100,000 high-skilled talents [1] - Additional training will be provided for cultural restoration, creative design, and rural tourism, targeting 30,000 individuals and adding 10,000 high-skilled talents [1] - The plan also includes training for new business models like live-streaming e-commerce and specialty catering, with a target of 30,000 individuals and 8,000 new high-skilled talents [1] Group 3: Digital Economy Sector - The digital skills training will focus on smart manufacturing, industrial internet, virtual reality, and blockchain, with a target of training 50,000 individuals and adding 15,000 high-skilled talents [2] - Youth skill training will be emphasized, particularly for new-generation migrant workers and veterans, with a target of training 150,000 individuals and adding 10,000 skilled technicians [2] Group 4: Vocational Education - The plan aims to expand enrollment in vocational schools, targeting over 55,000 students annually, and to establish industry-education alliances for practical training [2] - A total of 450,000 individuals are expected to be trained, with 260,000 new high-skilled talents [2] Group 5: Private Sector Involvement - The plan encourages private enterprises to lead or participate in skill ecosystem construction, targeting 150,000 individuals for training and adding 50,000 high-skilled talents [3] - The implementation of the "New Eight-Level Worker" skill grading system is also emphasized, with plans to evaluate 20 enterprises and 30 new top-level technicians [3]

Market Overview - On May 30, the A-share market experienced a decline, with the Shanghai Composite Index falling by 0.47%. The total trading volume for the day was 1.16 trillion yuan, with over 1,100 stocks rising and more than 4,100 stocks declining. There were 53 stocks that hit the daily limit up, while 19 stocks hit the limit down [1]. Sector Performance - The agriculture, forestry, animal husbandry, and fishery sector rose by 1.2%, led by concepts such as pork and poultry farming. Notable gainers included Juxing Agriculture and Animal Husbandry and Xiangjia Co., which hit the daily limit up [1]. - The innovative drug sector continued its strong performance, closing up by 1.56%, with eight stocks hitting the daily limit up, including Ruizhi Pharmaceutical and Hainan Haiyao [1]. Historical Highs - A total of 25 stocks reached their historical closing highs, with a focus on the pharmaceutical, banking, and transportation sectors. The average increase for these stocks was 5.64%, with notable gainers including Warner Pharmaceuticals and Limin Co. [1][2]. Institutional Trading - On May 30, ten stocks were net bought by institutions, with Sifang Precision and Shutai Shen receiving net purchases of 152 million yuan and 110 million yuan, respectively. Conversely, Haoyuan Pharmaceutical and Zhongchao Holdings faced net sell-offs exceeding 50 million yuan [3][4]. Northbound Capital - Northbound capital saw significant net purchases in five stocks, with Sifang Precision and Yunnei Power each receiving over 100 million yuan in net buys. The stock with the highest net sell was Rongfa Nuclear Power, with a net sell of 61.56 million yuan [5]. Corporate Announcements - Bohai Automobile plans to acquire stakes in several companies through a combination of share issuance and cash payment, with the stock expected to be suspended for up to 10 trading days starting June 3, 2025, due to this major asset restructuring [6]. - Aerospace Changfeng announced that it has been suspended from participating in military procurement activities, which may impact its logistics support equipment business in the short term [6]. - Lan Jian Intelligent proposed a share buyback plan using 10 to 20 million yuan of its own funds for employee stock ownership plans or equity incentives [6]. Fundraising and Projects - Vogt Optoelectronics intends to raise no more than 1.5 billion yuan for a MiniLED display backlight module project and to supplement working capital [8]. - China Communications Construction Company plans to repurchase shares worth 500 million to 1 billion yuan to reduce registered capital, with a repurchase price not exceeding 13.58 yuan per share [8].

证券代码：600252 证券简称：中恒集团 公告编号：临 2025-55 广西梧州中恒集团股份有限公司 关于控股股东筹划公司控股权内部调整的提示性公告 ●广西梧州中恒集团股份有限公司（以下简称"公司"）控股股东广西投资 集团有限公司（以下简称"广投集团"）拟以其所持有的公司 859,343,587 股（占 公司总股本的 25.94%）无限售条件流通股股份对其控股公司广西投资集团金融 控股有限公司（以下简称"广投金控"）进行增资扩股（以下简称"本次交易"）。 ●目前，广投集团为广投金控的间接控股股东，广投集团、广投金控和公司 的实际控制人均为广西壮族自治区国有资产监督管理委员会（以下简称"广西国 资委"），本次交易属于同一控制下的国有股权变动。本次交易完成后，公司控 股股东将变更为广投金控，公司实际控制人仍为广西国资委。 ●上述事项尚处于筹划阶段，尚需履行国资审批程序及相关法定程序。截至 本公告披露日，广投集团与广投金控尚未签订相关协议。敬请广大投资者理性投 资并注意投资风险。 一、本次交易的基本情况 公司于 2025 年 5 月 30 日收到控股股东广投集团的通知，广投集团拟以其所 持有的公司 859,343 ...

雷达财经 文|杨洋 编|李亦辉 在业绩方面，公司2022年至2024年营业收入分别为86.94亿元、100.58亿元和107.88亿元，同比分别增长8.38%、15.69%和7.25%。归母净利润分别为24.72亿 元、27.97亿元和29.77亿元，归母净利润同比增长分别为1.66%、13.15%和6.42%。同期，公司资产负债率分别为19.04%、18.50%和15.40%。 在风险方面，天眼查信息显示，公司自身天眼风险108条，周边天眼风险273条，历史天眼风险4条，预警提醒天眼风险423条。 天眼查资料显示，片仔癀成立于1999年12月28日，注册资本60331.721万人民币，法定代表人林志辉，注册地址为福建省漳州市芗城区琥珀路1号。主营业务 为医药制造业、医药流通业及化妆品业等。 目前，公司董事长为林志辉，董秘为施艺雄，员工人数为2839人，实际控制人为漳州市人民政府国有资产监督管理委员会。 公司参股公司55家，包括福建片仔癀电子商务有限公司、漳州片仔癀投资管理有限公司、福建片仔癀健康科技有限公司、片仔癀电商国际贸易（香港）有限 公司、漳州片仔癀国药堂医药连锁有限公司等。 5月30日，漳州片公告， ...

Investment Rating - The report indicates a positive investment outlook for the smart industry sector, particularly focusing on AI, robotics, and semiconductor technologies [1]. Core Insights - The Guangdong Smart Industry Fund has been launched with a target size of 10 billion yuan, aiming to drive technological breakthroughs and application scenarios in AI, smart manufacturing, and smart cities [1]. - The Wu Chuang Jiang'an Science and Technology Innovation Fund has been established to facilitate the transformation of major scientific achievements from top research institutions in Beijing to Wuhan, enhancing the local innovation ecosystem [3]. - AusperBio has successfully completed a $50 million B+ round financing to support the clinical development of its innovative drug for chronic hepatitis B [4]. - Tantu Intelligent has raised several hundred million yuan in a B round financing to enhance its core component development and expand its product categories [5]. - Hongxing Zhixin has completed a strategic financing of 143 million yuan, focusing on integrated circuit chip manufacturing and design services [7]. - The Handback Group has gone public on the Hong Kong Stock Exchange, offering a digital platform for life insurance transactions and services [8]. Summary by Sections Fundraising Events - The Guangdong Smart Industry Fund aims to raise 2 billion yuan in its first phase, focusing on AI, robotics, and semiconductor technology [1]. - The Wu Chuang Jiang'an Science and Technology Innovation Fund is set to leverage resources from Beijing to promote innovation in Wuhan [3]. Major Financing - AusperBio has completed a $50 million financing round to advance its drug development for chronic hepatitis B [4]. - Tantu Intelligent has secured several hundred million yuan in financing to boost its R&D and product offerings [5]. - Hongxing Zhixin has raised 143 million yuan for its integrated circuit chip business [7]. Global IPO - The Handback Group has launched its IPO on the Hong Kong Stock Exchange, focusing on digital insurance solutions [8]. Policy Focus - The State Council has issued guidelines to enhance the market-oriented allocation of resource and environmental factors by 2027, promoting active trading and efficient allocation [9].

Group 1: Stablecoin Legislation in Hong Kong - The Hong Kong Legislative Council passed the "Stablecoin Ordinance" on May 21, marking Hong Kong as one of the first regions globally to establish a comprehensive regulatory framework for fiat-backed stablecoins [1] - The Hong Kong Monetary Authority (HKMA) will initiate a licensing system to regulate stablecoin issuance and related activities, with compliance applications expected to be accepted by the end of 2025 [1] - Stablecoins are seen as a means to promote the internationalization of the Hong Kong dollar and the Renminbi, challenge the dominance of the US dollar in the digital currency era, and enhance the cross-border payment environment [1] Group 2: Investment Opportunities and Benefits - Issuers of stablecoins can gain commercial benefits such as minting profits, increasing user engagement within their ecosystems, and expanding customer reach, particularly among unbanked populations [1] - Investors can benefit from stablecoins by avoiding cryptocurrency volatility, meeting cross-border payment needs, participating in DeFi investments, and managing liquidity [1] - Licensed institutions are expected to generate revenue through a combination of interest spreads, fees, and ecosystem services [1] Group 3: Company Announcements and Financial Performance - China Eastern Group reported a sales volume of approximately 1.8 million tons of self-produced steel products for the first quarter, with a gross profit of about 100-150 RMB per ton [9] - Shenzhen Expressway reported a revenue of 97.14 million RMB for its outer ring project in April, reflecting a year-on-year decrease of approximately 9.21% [10] - Sany International reported a revenue of 5.876 billion RMB for the first quarter, a year-on-year increase of 14.6%, with a net profit attributable to shareholders of 635 million RMB, up 23.2% [17]

Market Overview - On May 29, the A-share market saw major indices fluctuate and close higher, with the Shanghai Composite Index rising by 0.7%. The total trading volume reached 1.21 trillion yuan, an increase of nearly 180 billion yuan compared to the previous trading day. Approximately 4,500 stocks closed higher, while 831 stocks declined, with 120 stocks hitting the daily limit up and 16 stocks hitting the limit down [1]. Sector Performance - The digital currency sector led the market with a 6.5% increase, featuring over 10 stocks hitting the daily limit up, including Lakala, Xiongdi Technology, and Sifang Chuangxin [1]. - The innovative drug sector also performed strongly, with stocks like Ruizhi Pharmaceutical, Shutaishen, and Yifang Bio-U hitting the daily limit up. Shutaishen's stock price has surged by 108.7% over the past eight trading days, with individual investors buying 4.832 billion yuan worth of shares, accounting for 65.17% of total purchases [1]. - The autonomous driving sector experienced a wave of limit-up stocks, including Sanyou Technology and Wanma Technology [1]. Historical Highs - A total of 27 stocks reached historical closing highs, with the pharmaceutical and biological sector leading with 8 stocks, followed by machinery equipment with 6 stocks, and retail with 2 stocks. The average increase for these stocks was 7.5% [2][3]. Institutional Activity - On May 29, 8 stocks saw net purchases exceeding 10 million yuan from institutions, with Wangzi New Materials leading at 41.11 million yuan. Other notable net purchases included Sifang Chuangxin and Jiusheng Electric, each exceeding 30 million yuan [4][5]. - Conversely, Xiongdi Technology faced a net sell-off exceeding 100 million yuan, with other stocks like Yong'an Pharmaceutical and Youfu Co., Ltd. also experiencing significant net selling [4]. Northbound Capital - Northbound capital saw significant net purchases, with Sifang Chuangxin receiving 149.95 million yuan, followed by Lakala with 89.21 million yuan. The largest net sell-offs were recorded for Xue Ren Co., Ltd. and Guangju Energy [6]. Company Announcements - Guangyang Co., Ltd. announced the termination of its planned acquisition of Ningbo Yinqiu Technology Co., Ltd. due to a lack of consensus among parties involved. The stock will resume trading on May 30 [7]. - Fengcai Technology is in the process of applying for an H-share listing on the Hong Kong Stock Exchange and has received a filing notice from the China Securities Regulatory Commission [7]. - Zhongke Xingtou announced that it has been suspended from participating in military procurement activities starting May 28, 2025 [7]. - Pingao Co., Ltd. signed a service contract worth 397 million yuan with Shenzhen Yuanmai for providing computing power resources [7]. - Zoomlion plans to issue asset-backed securities (ABS) up to 4 billion yuan and credit bonds up to 1 billion yuan [7]. Land Acquisition - Xiaoshangpin City successfully acquired a state-owned construction land use right in Hangzhou for 569 million yuan, intended for the Yiwu market project [8].

Group 1 - The core point of the article is that Jiyuan Holdings Group Co., Ltd. (*ST Jiyuan) will be delisted from the Shenzhen Stock Exchange on May 29, 2025, due to triggering mandatory delisting rules after its stock price remained below 1 yuan for 20 consecutive trading days [1][3] - The company has experienced continuous losses since 2019, with a cumulative net profit loss exceeding 3.2 billion yuan from 2019 to 2023 [3] - Jiyuan Holdings has faced significant goodwill impairment risks, totaling over 1.5 billion yuan from 2019 to 2024, which has directly contributed to its net profit losses [3] Group 2 - The company was originally known as Tonghua Shuanglong Chemical Co., Ltd. and transitioned to the pharmaceutical sector in 2014 through the acquisition of Jinbao Pharmaceutical [3] - Since its rebranding in 2017, the company has aggressively pursued mergers and acquisitions, acquiring over ten companies within three years, leading to a dual business model of "chemicals + pharmaceuticals" [3] - In 2024, the company's revenue declined by 3.69%, and its losses expanded to 439 million yuan [3] Group 3 - As of 2025, a total of 11 companies have been delisted from the A-share market, with *ST Jiyuan being one of them, alongside others like *ST Meixun and *ST Bo Xin [4] - The reasons for delisting include breaches of face value, market value, voluntary delisting applications, and forced delisting due to major violations [4]

Group 1 - The core viewpoint of the articles highlights the internationalization progress of Guangzhou Pharmaceutical Group, particularly through its subsidiary Wanglaoji, which is expanding its presence in Southeast Asia by establishing local production partnerships [1][2][3] - Wanglaoji signed production cooperation agreements with Malaysia's Baosteel Can Company and P.C.I. to enhance its local production capabilities and distribution networks in Malaysia, aiming to penetrate the broader Southeast Asian market [2][3] - The company emphasizes a strategy of localization, adapting its branding and packaging to fit local consumer habits and cultural preferences, as part of its global expansion efforts [2] Group 2 - Guangzhou Pharmaceutical Group is recognized as the first company primarily focused on traditional Chinese medicine to enter the Fortune Global 500, with its products exported to over 100 countries and regions [1] - Wanglaoji has established a comprehensive channel network in Southeast Asia, Europe, Africa, and has been the global leader in natural plant beverage sales for five consecutive years, according to Frost & Sullivan data [3] - The collaboration with Baosteel Can Company marks the first tangible project under their global strategic partnership, with an annual production capacity of 800 million cans [2]

Group 1 - Several ST companies, including *ST Dongyuan and *ST Kexin, have applied to remove their ST status following the annual report disclosures, with over 10 companies achieving this since May [1] - The reasons for the removal of delisting risk warnings include improvements in financial indicators, such as turning losses into profits through restructuring and rectifying previous issues related to fund occupation and internal controls [1] - *ST Dongyuan announced that its stock would be suspended for one day on May 28 and would resume trading on May 29, with the removal of delisting risk warnings and a change in stock name to "Dongfang Garden" [1] Group 2 - Many ST companies experienced significant stock price increases prior to the removal of their ST status, but saw declines immediately after, indicating that the positive news may have already been priced in [2] - Despite the removal of ST status, some companies still reported poor performance, such as Jinshi Technology, which had a revenue of 376 million yuan but a net loss of 4.397 million yuan last year [2] - Certain ST stocks that have removed their ST status still face potential investor claims, as seen with *ST Nongshang, which may face lawsuits for failing to disclose its 2023 performance forecast [2]